Clinical trial
A European, Randomised, Double-blind, Active Comparator Controlled, Cross-over, Efficacy and Safety Study of a New 10% Ready To-use Liquid Human Intravenous Immunoglobulin (I10E) Versus Kiovig® in Patients With Multifocal Motor Neuropathy
NCT01951924 is registered in ClinicalTrials.gov with Laboratoire français de Fractionnement et de Biotechnologies as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A European, Randomised, Double-blind, Active Comparator Controlled, Cross-over, Efficacy and Safety Study of a New 10% Ready To-use Liquid Human Intravenous Immunoglobulin (I10E) Versus Kiovig® in Patients With Multifocal Motor Neuropathy
- Lead sponsor
- Laboratoire français de Fractionnement et de Biotechnologies
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- July 31, 2016
- Enrollment
- 23 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.